Brief: Ryvu Therapeutics Says RVU120 To Be Tested In Phase I Study Run By IPCZD

Ryvu Therapeutics SA

09/09/2025 10:43

Sept 9 (Reuters) - Ryvu Therapeutics SA RVU.WA:

RVU120 TO BE TESTED IN PHASE I STUDY FOR PEDIATRIC MEDULLOBLASTOMA RUN BY IPCZD

IPCZD TO RUN "MEDWAY" PROJECT

UNDER MEDWAY PROJET 2 MILLION PLN TO BE ALLOCATED FOR RVU120 PRODUCTION

FIRST DELIVERY OF RVU120 PLANNED FOR Q2 2026

Source text: ID:nEM3W2cmda

Further company coverage: RVU.WA

 (Reporting by Gdańsk Newsroom)

 ((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))